For media enquiries and interview requests please contact email@example.com or +44 1491 829395
Since joining CABI as CEO in 2005, I have developed a stronger focus on CABI’s customers, member countries and funding donors. This market-driven approach has been combined with an integrated communications strategy to present clear messages, both internally and externally about CABI’s core strengths. Internally, operational effectiveness and efficiency have improved so that the organization has delivered four consecutive years of surplus and now benefits from greater financial stability.
I am a professional Company Director with over 30 years experience of building international businesses in the life science industry. I have focussed on genomics, in major pharma, biotech and academic clients. I also have broad experience of initiating change and restructuring organizations, ranging from start-ups to FTSE 100/Nasdaq quoted companies.
Before taking up my current role with CABI, I was Chief Commercial Officer for Affymetrix Inc with accountability for Sales, Marketing, Product Development and Manufacturing. Prior to this, I was founder CEO of Oxagen Ltd where I raised a total of £50 million over three venture-backed financing rounds and secured commercial partnerships in addition to academic collaborations. A major part of my early career was with Amersham International (now part of GE Healthcare) covering diagnostics and radiopharmaceuticals as well as research products. I have also worked as a consultant with McKinsey and Company Inc. and in Marketing with Unilever.
I hold a BA and D.Phil in biochemistry from the University of York and diploma qualifications in marketing (CIM) and company directorship. My leisure interests are golf, motorsport, food and wine.